Mercer Global Advisors
TLSI icon

Mercer Global Advisors’s TriSalus Life Sciences TLSI Stock Holding History

Mercer Global Advisors’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.2K Buy
+6,196
New +$24.6K ﹤0.01% 4641

Other funds holding TLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mercer Global Advisors's TLSI Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in TriSalus Life Sciences (TLSI) in Q2 2026: 6,196 shares worth $28.2K. The stake represents ﹤0.01% of the portfolio and ranks #4641 among its holdings.

66 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Mercer Global Advisors held 6,196 shares of TriSalus Life Sciences worth $28.2K as of Q2 2026.
  • TriSalus Life Sciences was a new Mercer Global Advisors position in Q2 2026.
  • TriSalus Life Sciences made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4641 holding.
  • 66 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.